Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection

Journal of Clinical Investigation

Volumn 106, Issue 6, 2000, Pages

  Teng, Yen Tung A ^a   Nguyen, Hai ^b   Gao, Xuijuan ^a   Kong, Young Yun ^c   Gorczynski, Reginald M ^b   Singh, Bhagirath ^a   Ellen, Richard P ^b   Penninger, Josef M ^c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c AMGEN INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; LIGAND; OSTEOPROTEGERIN;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; ALVEOLAR BONE; ANIMAL MODEL; ARTICLE; CASE REPORT; CELLULAR IMMUNITY; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PERIODONTAL DISEASE; PERIODONTITIS; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0033805254     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10763     Document Type: Article

References (49)

1. Clark, W.B., and Loe, H. 1993. Mechanisms of initiation and progression of periodontal disease. Periodontol. 2000. 2:72-82.
2. Brown, L.J., Oliver, R.C., and Loe, H. 1990. Evaluating periodontal status of US employed adults. J. Am. Dent. Assoc. 121:226-232.
3. Eklund, S.A., and Burt, B.A. 1994. Risk factors for total tooth loss in the United States; longitudinal analysis of national data. J. Public Health Dent. 54:5-14.
4. Genco, R. 1997. Research news. Healthy gums for a happy heart. Science. 276:203.
5. Mattila, K.L., Valle, M.S., Nieminen, M.S., Valtonen, V.V., and Hietaniemi, K.L. 1993. Dental infections and coronary atherosclerosis. Atherosclerosis. 103:205-211.
6. DeStefano, F., Anda, R.F., Kahn, S., Williamson, D.F., and Russell, C.M. 1993. Dental disease and risk of coronary heart disease and mortality. Br. Med. J. 306:688-691.
7. Scannapieco, FA, and Mylotte, J.M. 1996. Relationship between periodontal disease and bacterial pneumonia. J. Periodontol. 67:1114-1122.
8. Danesh, J. 1999. Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: meta-analyses of prospective studies. Am. Heart J. 138:S434-S437.
9. Becker, J., Garcia, R., Heiss, G., Vokonas, P.S., and Offenbacher, S. 1996. Periodontal disease and cardiovascular disease. J. Periodontol. 67:1123-1137.
10. Zambon, J.Z. 1996. Periodontal diseases: microbial factors. Ann. Periodontol. 1:879-925.
11. Drown, L.J., and Loe, H. 1991. Juvenile periodontitis in the United States of America. J. Periodontol. 62:608-616.
12. Zambon, J.J. 1985. Actinobacillus actinomycetemcomitans in human periodontal disease. J. Clin. Periodontol. 12:1-20.
13. Zambon, J.J., et al. 1988. Actinobacillus actinomycetemcomitans in the pathogenesis of human periodontal disease. Adp. Dent. Res. 2:269-274.
14. Meyer, D.H., and Fives-Taylor, P.M. 1994. Characterization of adherence of Actinobacillus actinomycetemcomitans to epithelial cells. Infect. Immun. 62:928-935.
15. Fives-Taylor, P., Meyer, D.H., and Mintz, K. 1996. Virulence factors of the periodontopathogen Actinobacillus actinomycetemcomitans. J. Periodontol. 67(Suppl.):291-297.
16. Zambon, J.J., Haraszthy, V.I., Lally, E.T., and Denmuth, D.R. 1996. The microbiology of early-onset periodontitis: association of highly toxic Actinobacillus actinomycetemcomitans strains with localized juvenile periodontitis. J. Periodontol. 67:282-290.
17. Lally, E.T., Kieba, I.R., Golub, E.E., Lear, J.D., and Tanaka, J.C. 1996. Structure/function aspects of Actinobacillus actinomycetemcomitans leukotoxin. J. Periodontol. 67:298-308.
18. McArthur, W.P., and Clark, W.B. 1993. Specific antibodies and their potential role in periodontal diseases. J. Periodontol. 64:807-818.
19. Ebersole, J.L., and Taubman, M.A. 1994. The protective nature of host responses in periodontal diseases. Periodontol. 2000. 5:112-141.
20. Stoufi, E.D., Taubman, M.A., Ebersole, J.E., Smith, D.J., and Stashenko, P.P. 1987. Phenotypic analysis of mononuclear cells recovered from healthy and diseased human periodontal tissues. J. Clin. Immunol. 77:235-245.
21. Suzuki, J., Park, S.K., and Falker, W.A., Jr. 1984. Immunulogical profiles of juvenile periodontitis. I. Lymphocyte blastogenesis and the autologous mixed lymphocyte response. J. Periodontol. 55:453-459.
22. Yamashita, K., Eastcott, J.W., Taubman, M.A., Smith, DJ., and Cox, D.S. 1991. Effect of adoptive transfer of cloned Actinobacillus actinomycetemcomitans-specific T helper cells on periodontal disease. Infect. Immun. 59:1529-1534.
23. Eastcott, J.W., Yamashita, K., Taubman, M.A., Harada, Y., and Smith, D.J. 1994. Adoptive transfer of cloned T helper cells ameliorates periodontal disease in nude rats. Oral Microbiol. Immunol. 9:284-289.
24. Teng, Y.-T., et al. 1999. Periodontal immune responses of human lymphocytes in Actinobacillus actinomycetemcomitans-inoculatad NOD/SCII) mice engrafted with peripheral blood leukocytes of periodontitis patients. J. Periodontol. Res. 34:54-61.
25. Simonet, W.S., et al. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 89:309-319.
26. Lacey, D.L., et al. 1998 Osteoprotegerin ligand is a cytokine that regulates osreoclast differentiation and activation. Cell. 93:165-176.
27. Kong, Y.Y., et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 37:315-323.
28. Takahashi, N., Udagawa, N., and Suda, T. 1999. A new member of tumor necrosis factor ligand family. ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem. Biophys. Res. Commun. 256:449-455.
29. Anderson, D.M., et al. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390:175-179.
30. Hsu, H., et al 1999. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. USA. 96:3540-3545.
31. Kong, Y.Y., et al. 1999. Activated T cells regulate bone loss and joint destruction in arthritis via OGPL Nature. 402:304-309.
32. Sandhu, J., Shpitz, B., Gallinger, S., and Hozumi, N. 1994. Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. J. Immunol. 152:3808-3813.
33. Hozumi, N., Gorczynski, R.M., Peters, W., and Sandhu, J.S. 1994 A SCID mouse model for human immune response and disease. Res Immunol. 145:370-379.
34. Evans, R.T., et al. 1992. Periodontopathic potential of two strains of Porphyromonas ginggivalis in gnorobiotic rats. Arch. Oral Biol. 37:813-819.
35. Teng, Y.-T., Williams, D., Hozumi, N., and Gorczynski, R.M. 1996. Multiple levels of regulation for self tolerance in beef insulin transgenic mice. Cell Immunol. 173:183-191.
36. Asotora, S., Gupta, A.K., Sodek, J., Aubin, J.E., and Heersche, J.N.M. 1994. Carbonic anhydrase 2 mRNA expression in individual osteoclasts under "resorbing" and "nonresorbing" conditions. J. Bone Miner. Res. 9:1115-1122.
37. Baker, P.J., Evans, R.T., and Roopenian, D.C. 1994 Oral infection with Prophyromonas gingivalis and induced alveolar bone loss in immuno-competent and severe combined immunodeficient mice. Arch. Oral. Biol. 39:1035-1040.
38. Page, R.C. 1982. Periodontitis in man and other animals: a comparative review. Blackwell Publisher, Toronto, Canada. 60-71.
39. Baker, P.J., Dixon, M., Evans, R.T., Dufour, L., and Roopenian, D.C. 1999. CD4 (+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect. Immun. 67:2804-2809.
40. Lubberts, E., et al. 2000. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J. Clin. Invest. 105:1697-1710.
41. Wagner, U.G., Koetz, K., Weyand, C.M., and Goronzy, J.J. 1998. Perturbation of the T cell repertoire in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 95:14447-14452.
42. Goronzy, J.J., Zettl, A., and Weyand, C.M. 1999. T cell receptor repertoire in rheumatoid arthritis. Int. Rev. Immunol. 17:339-363.
43. Honore, P., et al. 2000. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat. Med. 6:521-528.
44. Kobayasbi, K., et al. 2000. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191:275-286.
45. Hofbauer, L.C., et al. 1999. Interleukin-1 beta and tumor necrosis factor-alpha, bur not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone. 25:255-259.
46. Hofbauer, L.C., et al. 2000. The roles of osteoproregerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J. Bone Miner. Res. 15:2-12.
47. Rani, C.S., and MacDougall, M. 2000. Dental cells express factors that regulate bone resorption. Mol. Cell Biol. Res. Commun. 3:145-152.
48. Kawashima, N., and Stashenko, P. 1999. Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation. Arch. Oral Biol. 44:55-66.
49. Gainet, J., et al. 1999. Neutrophil dysfunction, IL-8, and soluble L-selectin plasma levels in rapidly progressive versus adult and localized juvenile periodontitis: variations according to disease severity and microbial flora. J. Immunol. 163:5013-5019.